Global Transthyretin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transthyretin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Transthyretin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transthyretin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Familial Amyloid Neuropathies and Alzheimer's Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transthyretin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transthyretin key manufacturers include Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Pfizer Inc, Prothena Corp Plc and Regeneron Pharmaceuticals Inc, etc. Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc are top 3 players and held % sales share in total in 2022.
Transthyretin can be divided into AG-10, ALN-TTRsc02, CRX-1008 and EDE-1307, etc. AG-10 is the mainstream product in the market, accounting for % sales share globally in 2022.
Transthyretin is widely used in various fields, such as Familial Amyloid Neuropathies, Alzheimer's Disease, Cardomyopathy and Neuropathy, etc. Familial Amyloid Neuropathies provides greatest supports to the Transthyretin industry development. In 2022, global % sales of Transthyretin went into Familial Amyloid Neuropathies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transthyretin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Pfizer Inc
Prothena Corp Plc
Regeneron Pharmaceuticals Inc
Segment by Type
AG-10
ALN-TTRsc02
CRX-1008
EDE-1307
Inotersen Sodium
Others
Familial Amyloid Neuropathies
Alzheimer's Disease
Cardomyopathy
Neuropathy
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transthyretin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transthyretin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transthyretin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transthyretin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transthyretin introduction, etc. Transthyretin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Transthyretin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Transthyretin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transthyretin key manufacturers include Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Pfizer Inc, Prothena Corp Plc and Regeneron Pharmaceuticals Inc, etc. Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc are top 3 players and held % sales share in total in 2022.
Transthyretin can be divided into AG-10, ALN-TTRsc02, CRX-1008 and EDE-1307, etc. AG-10 is the mainstream product in the market, accounting for % sales share globally in 2022.
Transthyretin is widely used in various fields, such as Familial Amyloid Neuropathies, Alzheimer's Disease, Cardomyopathy and Neuropathy, etc. Familial Amyloid Neuropathies provides greatest supports to the Transthyretin industry development. In 2022, global % sales of Transthyretin went into Familial Amyloid Neuropathies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transthyretin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Pfizer Inc
Prothena Corp Plc
Regeneron Pharmaceuticals Inc
Segment by Type
AG-10
ALN-TTRsc02
CRX-1008
EDE-1307
Inotersen Sodium
Others
Segment by Application
Familial Amyloid Neuropathies
Alzheimer's Disease
Cardomyopathy
Neuropathy
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transthyretin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transthyretin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transthyretin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transthyretin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transthyretin introduction, etc. Transthyretin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Transthyretin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.